发明名称 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
摘要 The present invention relates to pharmaceutical compositions for the treatment of spinal disorders caused by the liberation of TNF-alpha comprising an effective amount of a TNF-alpha inhibitor, as well as a method for treatment of such disorders, and the use of TNF-alpha inhibitors in the preparation of pharmaceutical compositions for such treatment.
申请公布号 US6635250(B2) 申请公布日期 2003.10.21
申请号 US20010760810 申请日期 2001.01.17
申请人 A+ SCIENCE AB (PUBL) 发明人 OLMARKER KJELL;RYDEVIK BJOERN
分类号 C07D215/22;A61K31/00;A61K31/16;A61K31/165;A61K31/19;A61K31/33;A61K31/40;A61K31/44;A61K31/445;A61K31/495;A61K31/496;A61K31/50;A61K31/501;A61K31/522;A61K31/535;A61K31/56;A61K31/65;A61K38/17;A61K38/55;A61K39/395;A61K45/00;A61K45/06;A61P25/00;A61P25/02;A61P37/00;A61P43/00;C07D213/22;C07D401/04;C07D473/06;C07D491/107;C07K16/28;(IPC1-7):A61K39/395;A61K38/00;A61K38/19 主分类号 C07D215/22
代理机构 代理人
主权项
地址